Effects of spleen status on early outcomes after hematopoietic cell transplantation

Autor: Marcelo C. Pasquini, Manza A. Agovi, David I. Marks, Vikas Gupta, Hillard M. Lazarus, Gorgun Akpek, Richard T. Maziarz, J D Rizzo, Uday R. Popat, O Ringdén, Kenneth R. Cooke, Martin Bornhaeuser, P.L. McCarthy, Karen K. Ballen, Brent R. Logan, Brian J. Bolwell, Vincent T. Ho, Dipnarine Maharaj
Rok vydání: 2012
Předmět:
Adult
Male
medicine.medical_specialty
Time Factors
Adolescent
Platelet Engraftment
medicine.medical_treatment
Splenectomy
Spleen
Hematopoietic stem cell transplantation
stem cell transplantation
Gastroenterology
Article
splenectomy
Disease-Free Survival
03 medical and health sciences
0302 clinical medicine
Internal medicine
medicine
Humans
myeloproliferative disease
Survival rate
Retrospective Studies
Transplantation
Neutrophil Engraftment
business.industry
Hematopoietic Stem Cell Transplantation
Engraftment
Hematology
Middle Aged
Allografts
medicine.disease
3. Good health
Survival Rate
surgical procedures
operative

medicine.anatomical_structure
Graft-versus-host disease
Hematologic Neoplasms
030220 oncology & carcinogenesis
Immunology
spleen
Female
business
Follow-Up Studies
030215 immunology
Zdroj: Bone marrow transplantation
ISSN: 1476-5365
0268-3369
Popis: To assess the impact of spleen status on engraftment and early morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT), we analyzed 9,683 myeloablative allograft recipients from 1990 to 2006; 472 had prior splenectomy (SP), 300 splenic irradiation (SI), 1,471 with splenomegaly (SM), and 7,440 with normal spleen (NS). Median times to neutrophil and platelet engraftment were 15 vs. 18 days and 22 vs. 24 days for the SP and NS groups, respectively (p5.7x106/kg improved platelet engraftment at day+28. After adjusting variables by Cox regression, the incidence of graft-versus-host disease (GVHD) and overall survival were not different among groups. Splenomegaly is associated with delayed engraftment while splenectomy prior to HCT facilitates early engraftment without impact on survival.
Databáze: OpenAIRE